CIAS
ARNA

Capital Investment Advisory Services’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Capital Investment Advisory Services’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-700
Closed -$32K – 1356
2019
Q3 		$32K Hold
700
– – 0.01% 674
2019
Q2 		$44K Buy
+700
New +$36.2K 0.01% 584

Other funds holding ARNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Capital Investment Advisory Services's ARNA Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2019, closing a stake of 700 shares — an estimated $32K sold.

Capital Investment Advisory Services first reported a position in ARNA in Q2 2019 and held it in 2 quarters. The position peaked at $44K in Q2 2019. 226 funds tracked by Wall St. Rank hold ARNA as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining Arena Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 700 Arena Pharmaceuticals Inc shares in Q4 2019, an estimated $32K.
  • Capital Investment Advisory Services first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 2 quarters.
  • Capital Investment Advisory Services's Arena Pharmaceuticals Inc position peaked at $44K in Q2 2019.
  • 226 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.